ABSTRACT & COMMENTARY

Diagnostic Uncertainty in Community-Acquired Pneumonia

Name: Relias Media
Price range: $

October 30, 2024

A national retrospective cohort study from the Veterans Administration found a high rate of diagnostic discordance for patients admitted and discharged for community-acquired pneumonia (CAP). Improvement in the diagnosis of CAP is needed.

Issue Date: October 30, 2024

Table of Contents

Dr. Stephen Brunton, physician editor, reports he is on the speakers bureau and advisory board for AstraZeneca, Astellas, Bayer, Boehringer Ingelheim, Novo Nordisk, and Renalytix; is on the speakers bureau for Eli Lilly; is on the advisory board for Abbott Diabetes, Phathom, Sanofi, Kowa, Haleon, and Biolinq; and is a stockholder with Paracrine. The relevant financial relationships listed for this individual have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements